GB0203526D0 - Process and composition - Google Patents

Process and composition

Info

Publication number
GB0203526D0
GB0203526D0 GB0203526A GB0203526A GB0203526D0 GB 0203526 D0 GB0203526 D0 GB 0203526D0 GB 0203526 A GB0203526 A GB 0203526A GB 0203526 A GB0203526 A GB 0203526A GB 0203526 D0 GB0203526 D0 GB 0203526D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0203526A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0203526A priority Critical patent/GB0203526D0/en
Publication of GB0203526D0 publication Critical patent/GB0203526D0/en
Priority to CA002475659A priority patent/CA2475659A1/en
Priority to ES03700915T priority patent/ES2263949T3/en
Priority to KR1020047012580A priority patent/KR100967782B1/en
Priority to DK03700915T priority patent/DK1476136T3/en
Priority to BR0307666-0A priority patent/BR0307666A/en
Priority to MXPA04007857A priority patent/MXPA04007857A/en
Priority to US10/503,750 priority patent/US20050075335A1/en
Priority to PL371963A priority patent/PL206544B1/en
Priority to PT03700915T priority patent/PT1476136E/en
Priority to AT03700915T priority patent/ATE329581T1/en
Priority to AU2003202058A priority patent/AU2003202058B2/en
Priority to NZ534333A priority patent/NZ534333A/en
Priority to RU2004127450/15A priority patent/RU2329789C2/en
Priority to JP2003567377A priority patent/JP2005523276A/en
Priority to DE60306120T priority patent/DE60306120T2/en
Priority to SI200330355T priority patent/SI1476136T1/en
Priority to PCT/GB2003/000217 priority patent/WO2003068193A1/en
Priority to EP03700915A priority patent/EP1476136B1/en
Priority to CO04078329A priority patent/CO5611095A2/en
Priority to IS7398A priority patent/IS2393B/en
Priority to NO20043834A priority patent/NO20043834L/en
Priority to HK05103665A priority patent/HK1072359A1/en
Priority to CY20061101205T priority patent/CY1106148T1/en
Ceased legal-status Critical Current

Links

GB0203526A 2002-02-14 2002-02-14 Process and composition Ceased GB0203526D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0203526A GB0203526D0 (en) 2002-02-14 2002-02-14 Process and composition
EP03700915A EP1476136B1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation
AT03700915T ATE329581T1 (en) 2002-02-14 2003-01-22 PHARMACEUTICAL FORMULATION CONTAINING N-((1-N-BUTYL-4-PIPERIDINYL)MENTHYL)-3,4-DIHYDR -2H-(1, 3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE OR AN EQUIVALENT SALT CONTAINED HEREIN, AND THEIR MANUFACTURING PROCESS, WHICH INCLUDES DRY GRANULATION
NZ534333A NZ534333A (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide or salt, and process for preparing thereof comprising dry granulation
KR1020047012580A KR100967782B1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n-1-n-butyl-4-piperidinylmethyl-3,4-dihydro-2h-1,3oxazino3,2-aindole-10-carboxamide or salt and process therefor comprising dry granulation
DK03700915T DK1476136T3 (en) 2002-02-14 2003-01-22 A pharmaceutical composition comprising N - [(1-N-butyl-4-piperidinyl) methyl] -3,4-dihydro-2H- [1,3] oxazino [3,2-a] indole-10-carboxamide or salt and, therefore, the method comprising dry granulation
BR0307666-0A BR0307666A (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n - [(1-n-butyl-4-piperidinyl) methyl] -3,4-dihydro-2h [1-3] oxazole (3,2-a) indole-10-carboxamide or salt and process for this comprising dry granulation
MXPA04007857A MXPA04007857A (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation.
US10/503,750 US20050075335A1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation
PL371963A PL206544B1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
PT03700915T PT1476136E (en) 2002-02-14 2003-01-22 PHARMACEUTICAL COMPOSITION UNDERTAKING N - ((1-N-BUTYL-4-PIPERIDINYL) METHYL) -3,4-DIHYDRO-2H- (1,3) OXAZINE (3,2-A) INDOLE-10-CARBOXAMIDE OR SALT AND PROCESS OF OBTAINING COMPREHENDING GRANULACAO A DRY.
CA002475659A CA2475659A1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
AU2003202058A AU2003202058B2 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising N- ((1-N-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2H- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
ES03700915T ES2263949T3 (en) 2002-02-14 2003-01-22 PHARMACEUTICAL COMPOSITION INCLUDING N - (((1-N-BUTIL-4-PIPERIDINIL) MENTIL) -3,4-DIHIDRO-2H- (1,3) OXAZINO (3,2-AINDOL-10-CARBOXAMIDE OR A SALT OF THE SAME AND PROCEDURE FOR YOUR PREPARATION THAT INCLUDES DRY VIA GRANULATION.
RU2004127450/15A RU2329789C2 (en) 2002-02-14 2003-01-22 PHARMACEUTICAL COMPOSITION CONTAINING N-[(1-nBUTYL-4-PIPERIDINYL) METHYL]-3,4-DIHYDRO-2N-[1,3]OXAZINO[3,2-a]INDOLE-10- CARBOXAMIDE OR ITS SALT, AND RELATED PRODUCTION METHOD INCLUDING AIR-STREAM GRANULATION
JP2003567377A JP2005523276A (en) 2002-02-14 2003-01-22 N-[(1-N-butyl-4-piperidinyl) methyl] -3,4-dihydro-2H- [1,3] oxazino [3,2-A] indole-10-carboxamide (SB207266) or a salt thereof And methods involving dry granulation operations
DE60306120T DE60306120T2 (en) 2002-02-14 2003-01-22 PHARMACEUTICAL FORMULATION, THE N - ((1-N-BUTYL-4-PIPERIDINYL) MENTHYL) -3,4-DIHYDRO-2H- (1,3) OXAZINO (3,2-A) INDOL-10-CARBOXAMIDE OR A CORRESPONDING SALT HEREBY CONTAINS, AS WELL AS THEIR MANUFACTURING PROCESS, WHICH CONTAINS DRY GRANULATION
SI200330355T SI1476136T1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation
PCT/GB2003/000217 WO2003068193A1 (en) 2002-02-14 2003-01-22 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
CO04078329A CO5611095A2 (en) 2002-02-14 2004-08-11 PHARMACEUTICAL COMPOSITION INCLUDING N - ((1-BUTIL-4- PIPERIDINIL) METHYL) -3,4-DIHIDRO-2H- (1,3) OXAZINO (3,2-A) INDOL -10-CARBOXAMIDE OR SALT OF THE SAME , AND PROCEDURE FOR THE SAME WHO INCLUDES DRY GRANULATION
IS7398A IS2393B (en) 2002-02-14 2004-08-12 A pharmaceutical composition comprising N - ((1-N-butyl-4-piperidinyl) methyl) -3,4-dihydro-2H- (1,3) oxazino (3,2-A) indole-10-carboxamide or salt and a method thereof involving dry granulation
NO20043834A NO20043834L (en) 2002-02-14 2004-09-13 Pharmaceutical composition comprising N - ((1-N-butyl-4-piperidinyl) methyl-3,4-dihydro-2H- (1,3) -oxazino (3,2-A) indole-10-carboxyamide or salts and methods therefore extensive dry granulation
HK05103665A HK1072359A1 (en) 2002-02-14 2005-04-28 Pharmaceutical composition comprising N-((1-N-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-A)indole-10carboxamide or salt and process for preparing thereof comprising dry granulation
CY20061101205T CY1106148T1 (en) 2002-02-14 2006-08-28 PHARMACEUTICAL COMPOSITION PEPILAMVANOUS N-((1-N-BUTYL-4-PIPEPIDINYL) METHYL)-3,4-DIHYDRO-2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE OR SALT AND METHOD FOR FRIDAY SHE RECEIVING DRY GRANULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203526A GB0203526D0 (en) 2002-02-14 2002-02-14 Process and composition

Publications (1)

Publication Number Publication Date
GB0203526D0 true GB0203526D0 (en) 2002-04-03

Family

ID=9931090

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203526A Ceased GB0203526D0 (en) 2002-02-14 2002-02-14 Process and composition

Country Status (1)

Country Link
GB (1) GB0203526D0 (en)

Similar Documents

Publication Publication Date Title
AU2003219942A8 (en) Composition and process for well cleaning
AU2003256805A8 (en) Compounds compositions and methods
GB0221513D0 (en) Novel compounds and processes
EP1684771A4 (en) Composition and method
GB0126643D0 (en) Composition and process
GB0220385D0 (en) Compound and process
GB0306657D0 (en) Process and compounds
GB0203528D0 (en) Process and composition
GB0317393D0 (en) Process and compounds
GB0215867D0 (en) Novel method and compounds
GB0206657D0 (en) Novel intermediate and process
GB0229243D0 (en) Compounds and process
GB0229445D0 (en) Process,composition and use
GB0211751D0 (en) Compound and process
GB0203526D0 (en) Process and composition
GB0225783D0 (en) Composition and process
GB0225782D0 (en) Composition and process
GB0225780D0 (en) Composition and process
GB0227876D0 (en) Process and supports
GB0217446D0 (en) Composition use and process
GB0217444D0 (en) Composition use and process
GB0217443D0 (en) Composition use and process
GB0217442D0 (en) Composition use and process
GB0107033D0 (en) Method and composition
GB0303581D0 (en) Process and composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)